Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...

In this conversation, Thomas McGinn, M.D., MPH, senior executive vice president and chief physician executive officer at CommonSpirit Health, shares how the organization aligns leadership, ...

In recent years, numerous landslides on hillsides in urban and rural areas have underscored that understanding and predicting ...

Trane expects commercial HVAC sales to remain strong in 2026, while residential sales are projected to be soft in the first quarter before improving in the second half of the year.

The implications of AI for data governance and security don’t often grab the headlines, but the work of incorporating this ...

Physna is licensing API access to its Physical AI search and normalization engine for a cohort of AI labs, OEMs, ...

Under the policy, Batten courses are guided by a grade normalization standard that aims for a class-wide mean GPA of approximately 3.5, rather than grading solely on raw scores or percentages.

New research from Dell’Oro Group shows how AI is impacting the entire data center infrastructure stack, from record ...

TIME, in partnership with Statista R, the leading global provider of market and consumer data and rankings, has published the ...

The Nashville airport is nearing normal operations again, three days after a massive winter storm hit the city. Here's what ...

Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.